GLP-1 receptor agonists are a class of injectable treatments for patients with type 2 diabetes that is often recommended as part of combination therapy when oral medication does not result in sufficient glycemic control [15, 25–27]. Here, GLP1R is linked to type 2 diabetes mellitus.